Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Pre-funded warrants
Common Stock
Pre-funded warrants
Additional Paid-In Capital
Pre-funded warrants
Preferred Stock
Series E-2 Preferred Stock
Preferred Stock
Series E-3 preferred stock
Preferred Stock
Common Stock
Series E-2 Preferred Stock
Common Stock
Series E-3 preferred stock
Common Stock
Additional Paid-In Capital
Series E-2 Preferred Stock
Additional Paid-In Capital
Series E-3 preferred stock
Additional Paid-In Capital
Accumulated Deficit
Series D preferred stock
Total
Balance beginning at Dec. 31, 2023           $ 4,677,632     $ 207     $ 182,924,210 $ (202,761,017)   $ (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023           319.76     20,744,110            
Balance beginning Series D preferred stock at Dec. 31, 2023                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                           111.11  
Stock-based compensation                       454,363     454,363
Exercise of warrants into common shares                 $ 5     2,298,138     2,298,143
Exercise of warrants into common shares (in shares)                 547,177            
Exercise of warrants for preferred stock, net of issuance costs           $ 47,577,000                 47,577,000
Exercise of warrants for preferred stock, net of issuance costs (in shares)           2,205                  
Conversion of preferred stock to common stock $ 11 $ 3,972,529 $ 3,972,540 $ (1,203,346) $ (33,983,571)   $ 9 $ 100   $ 1,203,337 $ 33,983,471        
Conversion of preferred stock to common stock (in shares) 1,079,132     82.26 (1,575)   903,956 9,890,099              
Retired shares (in shares)                 (8)            
Net loss                         (26,641,983)   (26,641,983)
Balance ending Series D preferred stock at Mar. 31, 2024                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2024                           111.11  
Balance ending at Mar. 31, 2024           $ 17,067,715     $ 332     224,836,048 (229,403,000)   12,501,095
Balance ending (in shares) at Mar. 31, 2024           867.5     33,164,466            
Balance beginning at Dec. 31, 2023           $ 4,677,632     $ 207     182,924,210 (202,761,017)   (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023           319.76     20,744,110            
Balance beginning Series D preferred stock at Dec. 31, 2023                           $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                           111.11  
Balance ending Series D preferred stock at Dec. 31, 2024                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Dec. 31, 2024                           111.11  
Balance ending at Dec. 31, 2024           $ 520,778     $ 461     261,115,905 (247,342,463)   14,294,681
Balance ending (in shares) at Dec. 31, 2024           35.6     46,079,875            
Stock-based compensation                       562,737     562,737
Conversion of preferred stock to common stock (in shares)               13,846,141              
Net loss                         (6,604,029)   (6,604,029)
Balance ending Series D preferred stock at Mar. 31, 2025                           $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2025                           111.11  
Balance ending at Mar. 31, 2025           $ 520,778     $ 461     $ 261,678,642 $ (253,946,492)   $ 8,253,389
Balance ending (in shares) at Mar. 31, 2025           35.6     46,079,875